enVVeno Medical
NVNO
5 hedge funds and large institutions have $298K invested in enVVeno Medical in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
72% more capital invested
Capital invested by funds: $173K → $298K (+$125K)
67% more funds holding
Funds holding: 3 → 5 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$187K |
| 2 |
Jane Street
New York
|
+$64.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$30.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$28.8K |
| 5 |
FIA
FNY Investment Advisers
New York
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$29K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $202K | +$187K | +104 | +173% |
|
|
2
Jane Street
New York
| $47K | +$64.8K | +36 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $22K | +$30.6K | +17 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $20K | +$28.8K | +16 | New |
|
|
FIA
5
FNY Investment Advisers
New York
| $7K | +$10.8K | +6 | New |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$29K | -12 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$2K | -1 | Closed |
|
NVNO Hedge Fund Activity: Q4 2018 in Review
5 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2018, worth a combined $298K — up 72% from $173K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NVNO positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $187K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $29K sold.
- 5 institutional investors held enVVeno Medical (NVNO) as of Q4 2018, up from 3 in Q3 2018.
- Funds reported $298K of enVVeno Medical stock for Q4 2018, up 72% quarter-over-quarter.
- 4 funds opened new enVVeno Medical positions in Q4 2018 and 2 closed out, a net change of +2 holders.
- The largest enVVeno Medical buyer in Q4 2018 was Vanguard Group, an estimated $187K added.
- The largest enVVeno Medical seller in Q4 2018 was Susquehanna International Group, an estimated $29K sold.
Based on aggregated 13F filings for Q4 2018.